Publications:

Characterization of cancer-associated IDH2 mutations that differ in tumorigenicity, chemosensitivity and 2-hydroxyglutarate production.

Oncotarget

Kotredes, Kevin P KP; Razmpour, Roshanak R; Lutton, Evan E; Alfonso-Prieto, Mercedes M; Ramirez, Servio H SH; Gamero, Ana M AM

Publication Date: 2019-04-12

Variant appearance in text: IDH1: R100A

PubMed Link: 31105869

Variant Present in the following documents:

• Main text
• oncotarget-10-2675.pdf

View BVdb publication page

IDH1 and IDH2 mutations in tumorigenesis: mechanistic insights and clinical perspectives.

Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research

Yang, Hui H; Ye, Dan D; Guan, Kun-Liang KL; Xiong, Yue Y

Publication Date: 2012-10-15

Variant appearance in text: IDH1: R100A

PubMed Link: 23071358

Variant Present in the following documents:

• Main text

View BVdb publication page

Identification of additional IDH mutations associated with oncometabolite R(-)-2-hydroxyglutarate production.

Oncogene

Ward, P S PS; Cross, J R JR; Lu, C C; Weigert, O O; Abel-Wahab, O O; Levine, R L RL; Weinstock, D M DM; Sharp, K A KA; Thompson, C B CB

Publication Date: 2012-05-10

Variant appearance in text: IDH1: R100A

PubMed Link: 21996744

Variant Present in the following documents:

• Main text

View BVdb publication page